CoChat

Nicotinamide Phosphoribosyltransferase in Human Diseases

Open access
Zhang, Li Qin, P. Heruth, Daniel, Qing Ye, Shui · 2011 · Journal of Bioanalysis & Biomedicine
Cited by 126

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Nicotinamide phosphoribosyltransferase (NAMPT) was cloned by Samal and his colleagues in 1994 from activated human peripheral blood lymphocytes during their attempt to discover new factors for the earliest events in B-cell development [1].The first NAMPT cDNA was screened out from those activated lymphocyte cDNA libraries using a degenerate oligonucleotide probe, which was designed on the basis of the similarity in the coding sequences of GM-CSF, IL-2, IL-1β, IL-6 and IL-13 at the signal peptidase processing site.NAMPT was initially named pre-B-cell colony enhancing factor (PBEF) after its function to promote pre-B-cell colony formation in the presence of stem cell factor plus interleukin 7.In the following ten years, PBEF received little notice.By 2004, only about 20 articles on PBEF were published in the literature.However, PBEF has garnered increasing attention in recent years due to accumulating evidence indicating that PBEF is a pleiotropic protein such as a growth factor, a cytokine, an enzyme and a visfatin.Until Dec 5, 2010, 712 publications have appeared in Pub Med when searched with key words: NAMPT OR pbef OR visfatin.To avoid the confusion, the name NAMPT will be used throughout this review since the NAMPT was approved as the official name of this gene by the Human Genome Organization Gene Nomenclature Committee.Because of NAMPT's multiple functions in a variety of physiological processes, their dysregulations have been implicated in the pathogenesis of a number of human diseases or conditions such as acute lung injury, aging, atherosclerosis, cancer, diabetes, rheumatoid arthritis and sepsis.This review will cover the current understanding of NAMPT structure and functions with an emphasis on recent progress of NAMPT's pathological roles in various human diseases and conditions.Future directions on exploring Terra incognita will be offered in the end. NAMPT structureThis section covers the NAMPT structure in three parts: Gene, mRNA and Protein.The regulatory components in the NAMPT gene promoter, evolutionary conservation of the coding sequence and some featured single nucleotide polymorphisms [SNP] in the NAMPT gene are described in the first part.mRNA species, isoforms and tissue distributions are recounted in the second part.The characteristics of the primary, secondary and three dimensional structure of the NAMPT protein are detailed in the third part.Gene: The human NAMPT gene spans a length of 36,908 bp on the position of chromosome 7:105, 675, 967-105,712, 874 according to the Human March 2006 Assembly on the University of California Santa Cruz Genome Browser.The NAMPT structural gene part is composed of 11 exons and 10 introns, which encodes 491 amino acids.Exon 1 encodes a short 5'-untranslated region and the signal peptide region, whereas exon 11 encodes the carboxyl end of the NAMPT protein and all of the 3' untranslated region.The GT and AG consensus splice junction sequences were well conserved at all of the exon/intron boundaries.The analysis of the regulatory gene part at the 3.2 kb 5'-flanking region upstream of the transcription initiation site revealed two segments: the proximal 1.4 kb is more GC rich (60% GC), whereas the distal 1.6 kb has more AT bases (60% AT) [2].Within the proximal region there is an extremely G+C-rich segment (72% GC) spanning the first 500 bp upstream of the major transcription initiation site, which lacks canonical TATA and CAAT boxes and contains several transcription initiation sites.In the distal region, however, several CAAT boxes and TATA-like and initiator sequences were found about 2 kb upstream from the transcription initiation site.This distal segment may act as a distal promoter.Several types of putative regulatory elements were identified.Multiple SP1 binding sites (GC-boxes) were found all along the 5'-flanking region; 12 of these were located at the predicted proximal promoter region.The binding sites for ubiquitous transcription factors such as the CCAAT/ nuclear factor 1, AP-1 and AP-2 were also identified.The binding sites for NF-1 were concentrated in the putative distal promoter region, those for AP-2 were mainly in the proximal promoter region, and AP-1 sites were uniformly distributed.In addition, the hormonally and chemically responsive regulatory elements, which include the binding sites for the glucocorticoid receptor, corticotropin releasing factor, cAMP response element binding protein and the nuclear factors such as NF-IL6, were present in both proximal and distal

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4172/1948-593x.1000038

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 11 references

Cited by

See all 126

Metadata

Authors
Zhang, L. Q., P. Heruth, D., & Qing Ye, S.
Venue
Journal of Bioanalysis & Biomedicine
Published
2011
Volume
03
Issue
01
Pages
13-25
ISSN
1948-593X (ISSN-L)
OpenAlex
W2011125600
Cited by
126
References
11
FWCI
5.83
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nicotinamide Phosphoribosyltransferase in Human Diseases. https://app.cochat.ai/papers/10.4172/1948-593x.1000038
The paper
Zhang, L. Q., P. Heruth, D., & Qing Ye, S. (2011). Nicotinamide Phosphoribosyltransferase in Human Diseases. Journal of Bioanalysis & Biomedicine. https://doi.org/10.4172/1948-593x.1000038

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.